Which diabetes pill combo wins? new study pits three top drugs against each other
NCT ID NCT06759922
First seen Nov 21, 2025 · Last updated Jun 11, 2026 · Updated 33 times
Summary
This study tested three different drug combinations (glimepiride, empagliflozin, or sitagliptin plus metformin) in 172 adults newly diagnosed with type 2 diabetes. Participants took one pill daily for 90 days, and researchers checked blood sugar, weight, and side effects. The goal was to find which combo works best and is safest for controlling diabetes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Medical Center
Karachi, Sindh, 75500, Pakistan
Conditions
Explore the condition pages connected to this study.